Balaxi Pharmaceuticals
Balaxi Pharmaceuticals Share Price Chart
Balaxi Pharmaceuticals last traded at ₹22.75 (2026-10-13). Over the past month the stock moved -2.1%, three months the stock moved -10.3%, year the stock moved -51.4%. Its closing range over 52 weeks is ₹16.48 – ₹42.94, with the latest close 47.0% below the high.
Closing prices up to 2026-10-13.
About Balaxi Pharmaceuticals
Balaxi Pharmaceuticals Ltd is an IPR-based pharmaceutical Company engaged in producing, stocking, selling, and supplying branded and generic medicines. [1]
Product Portfolio:[1] The Co's portfolio includes a balanced mix of generic and branded generic medicines. The strongest product categories are Antibiotics (84 products), Analgesics (65 products), Medical Devices (32 products) and Vitamins **(26 products) **
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Balaxi Pharmaceuticals reported sales of ₹80.68 crore (+14.1%) and net profit of ₹1.30 crore (+348.3%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 80.68 | 4.66 | 5.78 | 1.30 | 0.24 |
| Mar 2026 | 70.71 | 0.12 | 0.17 | 0.61 | 0.11 |
| Dec 2025 | 72.54 | 3.09 | 4.26 | 0.31 | 0.06 |
| Sep 2025 | 56.18 | 1.16 | 2.06 | 0.21 | 0.04 |
| Jun 2025 | 70.74 | 4.16 | 5.88 | 0.29 | 0.05 |
| Mar 2025 | 76.27 | 12.55 | 16.45 | 8.64 | 1.57 |
| Dec 2024 | 73.29 | 3.99 | 5.44 | 5.36 | 0.97 |
| Sep 2024 | 77.38 | 10.59 | 13.69 | 4.59 | 0.83 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +41.4% | +20.6% | +27.5% | +7.8% | -27.4% | -1.0% | -7.3% | +14.1% |
| Operating profit growth | -1.6% | -70.8% | -6.8% | -58.8% | -89.0% | -22.6% | -99.0% | +12.0% |
| Net profit growth | -68.2% | -60.6% | -21.0% | -95.5% | -95.4% | -94.2% | -92.9% | +348.3% |
| EPS growth | -70.6% | -63.4% | -21.9% | -95.7% | -95.2% | -93.8% | -93.0% | +380.0% |
| OPM % | 13.7% | 5.4% | 16.5% | 5.9% | 2.1% | 4.3% | 0.2% | 5.8% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Balaxi Pharmaceuticals reported sales of ₹270.00 crore (-7.8%) and net profit of ₹1.00 crore (-96.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 270.00 | 9.00 | 3.00 | 1.00 | 0.26 |
| Mar 2025 | 293.00 | 37.00 | 13.00 | 25.00 | 4.54 |
| Mar 2024 | 241.00 | 45.00 | 18.00 | -2.00 | -0.44 |
| Mar 2023 | 336.00 | 57.00 | 17.00 | 46.00 | 9.03 |
| Mar 2022 | 279.00 | 51.00 | 18.00 | 48.00 | 9.53 |
| Mar 2021 | 231.00 | 43.00 | 18.00 | 38.00 | 7.63 |
| Mar 2020 | 46.00 | 8.00 | 18.00 | 6.00 | 1.22 |
| Mar 2019 | 14.00 | 2.00 | 11.00 | 2.00 | 1.30 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales growth | +228.6% | +402.2% | +20.8% | +20.4% | -28.3% | +21.6% | -7.8% |
| Operating profit growth | +300.0% | +437.5% | +18.6% | +11.8% | -21.1% | -17.8% | -75.7% |
| Net profit growth | +200.0% | +533.3% | +26.3% | -4.2% | -104.3% | – | -96.0% |
| EPS growth | -6.2% | +525.4% | +24.9% | -5.2% | -104.9% | – | -94.3% |
| OPM % | 18.0% | 18.0% | 18.0% | 17.0% | 18.0% | 13.0% | 3.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Balaxi Pharmaceuticals.
Get Free AI Stock Analysis FREE →Latest News
-
Balaxi Pharmaceuticals Submits RTA Report on Physical Share Transfer Re-Lodgements for April 2026 - scanx.trade
-
Balaxi Pharmaceuticals Submits RTA Report on Physical Share Transfer Re-Lodgements for April 2026 - scanx.trade
-
Balaxi Pharmaceuticals gets nod to invest up to $4 million in Balaxi Global FZCO
-
Balaxi Pharmaceuticals gets nod to invest up to $4 million in Balaxi Global FZCO
Frequently Asked Questions
What is the share price of Balaxi Pharmaceuticals today?
Balaxi Pharmaceuticals shares were last quoted at ₹22.75 (+1.9% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Balaxi Pharmaceuticals?
Balaxi Pharmaceuticals has a price-to-earnings (P/E) ratio of 51.86 and a price-to-book (P/B) ratio of 0.50. The industry P/E is 33.17.
What is the 52-week high and low of Balaxi Pharmaceuticals?
The 52-week high of Balaxi Pharmaceuticals is ₹45.34 and the 52-week low is ₹15.20.
What is the market cap of Balaxi Pharmaceuticals?
The market capitalisation of Balaxi Pharmaceuticals is about ₹125.98 crore.
How did Balaxi Pharmaceuticals perform in its latest quarterly results?
In the latest quarter (Jun 2026), Balaxi Pharmaceuticals reported sales of ₹80.68 crore (+14.1%) and net profit of ₹1.30 crore (+348.3%), compared with the same quarter last year.
Is Balaxi Pharmaceuticals a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Balaxi Pharmaceuticals has a 3-year ROE of -4.00%, 3-year profit growth of -69.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Balaxi Pharmaceuticals?
Promoters hold about 65.99% of Balaxi Pharmaceuticals.
Which sector does Balaxi Pharmaceuticals belong to?
Balaxi Pharmaceuticals belongs to the Trading sector.